In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, is joined by William Morice II, M.D., Ph.D., president and CEO of Mayo Clinic Laboratories, to discuss seasonal vaccination planning and survey findings on laboratory industry growth. Later, Leslie Donato, Ph.D., a clinical chemist at Mayo Clinic, shares how an innovative testing panel is improving the diagnosis of bile acid malabsorption.

• Survey highlights laboratory growth strategies (00:29): Discover where laboratory leaders are investing, the challenges shaping the industry, and the strategies organizations are adopting to achieve sustainable growth.
• Seasonal viruses and vaccination planning (05:29): Discover how to learn more about vaccination options for viruses that typically surge during the fall and winter.
• Diagnostics for chronic diarrhea (07:43): Hear how a novel test is improving diagnosis and advancing understanding of bile acid malabsorption.

Resources

• Survey reveals four strategies for laboratory growth
• Vaccine and immunization guidance from Mayo Clinic
• Testing Options for Patients with Chronic Diarrhea: A Focus on Bile Acid Malabsorption Webinar
• Bile acid malabsorption: A patient-centered approach to diagnose a common cause of chronic diarrhea
• The right testing for an underrecognized cause of chronic diarrhea

In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, is joined by William Morice II, M.D., Ph.D., president and CEO of Mayo Clinic Laboratories, to discuss advancement in Alzheimer’s testing and practical uses of artificial intelligence (AI) in healthcare. Later, Dr. Pritt welcomes Chris Garcia, M.D., Mayo Clinic Laboratories’ chief digital innovation officer, to explore the evolving role of data in research and development.

• Innovative Alzheimer’s test gets FDA clearance (00:33): Dr. Morice shares how a strategic collaboration is enabling Mayo Clinic Laboratories to offer a newly FDA-cleared blood test for Alzheimer’s disease for adults with cognitive symptoms as young as 40.
• AI helping diagnose rare diseases (03:37): Dr. Pritt and Dr. Morice reflect on a recent article highlighting how AI is helping clinicians identify rare diseases.
• Data use in research and development (08:16): Dr. Garcia discusses how data, AI, and cross-disciplinary collaboration are advancing research and innovation in laboratory medicine.

Note: Information in this post was accurate at the time of its posting.

Resources

• C2N Diagnostics: FDA clears C2N Diagnostics’ PrecivityAD2® —First Alzheimer’s blood test for adults with cognitive symptoms as young as 40
• Wall Street Journal: AI is helping patients solve medical mysteries
• Answers From the Lab: Digital Advances: What's Next for Clinical Diagnostics?
• Answers From the Lab: Accelerating Research and Development With BioPharma Diagnostics

In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, is joined by William Morice II, M.D., Ph.D., president and CEO of Mayo Clinic Laboratories, to discuss Protecting Access to Medicare Act (PAMA) reform and recent reports about the New World screwworm. Dr. Morice also shares insights on building an innovation strategy that delivers meaningful organizational value.

• PAMA reform update (00:40): Dr. Morice discusses the status of the Reforming and Enhancing Sustainable Updates to Laboratory Testing Services (RESULTS) Act and PAMA.
• Tracking the New World screwworm (02:24): Learn about recent cases of the New World screwworm, why this parasitic fly is problematic, and how sterile insects help contain it.
• Developing an innovation strategy that drives value (04:49): Discover lessons from Dr. Morice’s experience developing a strategic approach to innovation that delivers meaningful outcomes and impact.

Resources

• 4 steps to establishing a new approach to innovation

In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, is joined by William Morice II, M.D., Ph.D., president and CEO of Mayo Clinic Laboratories, to discuss “rabbit fever” cases in New York and strategies for responding to industry trends. Later, Dr. Pritt welcomes Mary Jo Williamson, Mayo Clinic Laboratories’ chief administrative officer, to share practical strategies for leading teams through periods of rapid change.

• Strategies for making strategic progress amid disruption (00:29): Discover practical insights from a recent Forbes article by Dr. Morice on identifying healthcare industry disruptors and determining how organizations should respond.
• A rare tick-borne illness (07:21): Learn about suspected cases of the rare tick-borne illness tularemia, also known as "rabbit fever.”
• Leading through change (09:02): Williamson shares lessons from more than three decades of healthcare leadership, offering practical guidance for helping teams navigate change with confidence and purpose.

Resources

• Forbes: Understanding healthcare industry disruptors and what comes next
• Tick-borne disease: An expanding threat
• Five steps to manage change in an outreach laboratory
• Mary Jo Williamson talks resiliency and agility on Fierce Healthcare podcast
• Mary Jo Williamson shares strategic investment insights with Modern Healthcare

In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, is joined by William Morice II, M.D., Ph.D., president and CEO of Mayo Clinic Laboratories, to discuss the Protecting Access to Medicare Act (PAMA) and a recent Cyclospora outbreak making headlines. Later, Dr. Pritt welcomes Juliana Perez Botero, M.D., a Mayo Clinic hematologist, to explore innovative testing approaches for bleeding disorders.

• PAMA data collection and reform (01:05): With data collection for PAMA underway, Dr. Morice shares the latest on potential updates to the law.
• Cyclospora outbreak (05:45): Get a microbiologist’s perspective on the recent Cyclospora outbreak and learn practical steps to help reduce your risk of infection.
• The value of laboratory testing for bleeding disorders (08:37): Discover why laboratory testing plays a critical role in the diagnosis and management of patients with bleeding disorders.
• Innovation for bleeding disorder testing (12:56): Learn how genotype assays are enhancing patient care and how advances in nanotechnology and collaborative research are opening new possibilities for the future.

Resources

• Mayo Clinic Classical Hematology Conference
• Bleeding disorders: The right test at the right time
• Cyclospora Stain, Feces (Mayo ID: CYCL)

In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, is joined by William Morice II, M.D., Ph.D., president and CEO of Mayo Clinic Laboratories, to discuss recent artificial intelligence (AI) initiatives in the news. She then welcomes Jane Hermansen, manager of Mayo Clinic Laboratories’ Outreach Program, to discuss the value of outreach programs in strengthening laboratories and supporting broader healthcare systems.

• AI’s potential and limitations (00:01): Learn what’s next and the challenges that remain as Drs. Pritt and Morice discuss recent stories about AI in healthcare.
• Value of outreach (07:30): Discover how laboratory outreach programs support their organizations, delivering benefits that range from improved patient care to lower testing costs and growth across health system service lines.
• Getting the most from outreach (15:54): Learn the three most important things lab leaders can do to get the greatest value from their outreach program.
• The future of outreach (17:53): Get insights on how outreach may evolve in the coming years as healthcare changes.

Resources

• Fortune: A decade after the ‘Godfather of AI’ said radiologists are obsolete, salaries are $571K and growing
• “Answers From the Lab” podcast: Digital Advances: What's Next for Clinical Diagnostics?
• Personalized pathways through digital diagnostics: A Q&A with Chris Garcia, M.D.
• Outreach & Business Solutions
• Own your lab: Hospital-owned labs generate long-term financial and clinical value
• Leveraging the Laboratory Conference

In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, is joined by William Morice II, M.D., Ph.D., president and CEO of Mayo Clinic Laboratories, to discuss recent industry news and how clinical diagnostics are powering more personalized care. Together, they explore:

• Point-of-care testing in outbreak response (00:29): Hear about the potential and limitations of point-of-care testing during disease outbreaks.
• A rare type of Lyme disease (02:46): Learn about the spread of the second known pathogen to cause Lyme disease in the U.S.
• The evolution of AI (04:50): Dr. Morice shares insights from a recent conference, highlighting the shift from discussing artificial intelligence’s potential to scaling real-world clinical applications.
• Personalized medicine and diagnostics (06:07): Discover how clinical diagnostics are driving personalized medicine and how data will shape its future.

Resources

• Four ways diagnostics are driving more personalized care
• "Answers From the Lab" podcast: Advancing Precision Medicine Through Therapeutic Tests
• "Answers From the Lab" podcast: Risks Increase as Ticks, Mosquitoes, and Similar Vectors Spread
• Therapeutics testing: Discover the differences

In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, is joined by William Morice II, M.D., Ph.D., president and CEO of Mayo Clinic Laboratories, to discuss updates on the Protecting Access to Medicare Act (PAMA) and other policy changes affecting clinical diagnostics. Later, Dr. Pritt welcomes Ann Moyer, M.D., Ph.D., a molecular genetic pathologist at Mayo Clinic and chair of the hereditary genetics practice, to explore how precision therapeutics are improving cancer treatments.

• PAMA update (00:01): Get the latest on PAMA as the first data collection period begins, including ongoing efforts to advance the Reforming and Enhancing Sustainable Updates to Laboratory Testing Services (RESULTS) Act.
• Policy changes influencing diagnostics (04:09): Learn how evolving reimbursement policies for blood-based cancer screening and a proposed CLIA modernization bill may impact the field.
• Pharmacogenomic tests improving cancer care (08:14): Discover how pharmacogenomics are benefiting patients with cancer, the benefits of medication-based testing, and how this field is advancing.

Resources

• CMS: CLFS & PAMA reporting and resources
• Precision Oncology Therapeutics: Personalized cancer treatment
• Answers From the Lab: Genetic Tests Identify Risk of Irinotecan-Induced Toxicity: John Logan Black, M.D.
• Answers From the Lab: Genetic Tests Identify Risk of Fluoropyrimidine-Induced Toxicity: Ann Moyer, M.D., Ph.D.